Fennec Pharmaceuticals FENC
NASDAQ FENC
$10.64 +0.06 (+0.57%)
At close: Nov 11, 2026 · 4:00 PM EST

Fennec Pharmaceuticals (FENC) Gains (Losses) on Sale of Assets & Investments (2015 - 2025)

Updated

Fennec Pharmaceuticals' Non Operating Investment Income was $40,000 in FY2016.

Analysis

Fennec Pharmaceuticals (FENC) Gains (Losses) on Sale of Assets & Investments (2015 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Fennec Pharmaceuticals 370.66 Mn 230.50 Mn 17.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,000.00
Mar 31, 2025 -1,000.00
Dec 31, 2024 -67,000.00
Sep 30, 2024 -3,000.00
Mar 31, 2024 -11,000.00
Dec 31, 2023 4,000.00
Sep 30, 2023 -13,000.00
Mar 31, 2023 -30,000.00
Dec 31, 2022 -3,000.00
Sep 30, 2022 -27,000.00
Jun 30, 2022 -8,000.00
Mar 31, 2022 -91,000.00
Dec 31, 2021 -1,000.00
Sep 30, 2021 39,000.00
Jun 30, 2021 -84,000.00
Mar 31, 2021 182,000.00
Mar 31, 2018 167,000.00
Dec 31, 2017 37,000.00
Mar 31, 2017 -37,000.00
Dec 31, 2016 -43,000.00
API Access

Fennec Pharmaceuticals Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=FENC&period=max&api_key=YOUR_API_KEY